NATURAL HEALTH TRENDS CORP (NHTC)
US63888P4063 - Common Stock
NHTC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 37 industry peers in the Personal Care Products industry. While NHTC has a great health rating, there are worries on its profitability. NHTC does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year NHTC was profitable.
NHTC had a negative operating cash flow in the past year.
Of the past 5 years NHTC 4 years were profitable.
In multiple years NHTC reported negative operating cash flow during the last 5 years.
1.2 Ratios
NHTC has a Return On Assets (0.82%) which is in line with its industry peers.
NHTC has a Return On Equity (1.37%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.82% | ||
| ROE | 1.37% | ||
| ROIC | N/A |
ROA(3y)0.77%
ROA(5y)-0.33%
ROE(3y)1.27%
ROE(5y)-0.49%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of NHTC (1.29%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of NHTC has declined.
NHTC has a Gross Margin of 74.57%. This is amongst the best in the industry. NHTC outperforms 89.19% of its industry peers.
In the last couple of years the Gross Margin of NHTC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 1.29% | ||
| GM | 74.57% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y0.13%
PM growth 5Y-39.65%
GM growth 3Y0.88%
GM growth 5Y-1.27%
2. Health
2.1 Basic Checks
NHTC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NHTC has been increased compared to 1 year ago.
NHTC has more shares outstanding than it did 5 years ago.
NHTC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
NHTC has an Altman-Z score of 2.69. This is not the best score and indicates that NHTC is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of NHTC (2.69) is better than 62.16% of its industry peers.
There is no outstanding debt for NHTC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.69 |
ROIC/WACCN/A
WACC9%
2.3 Liquidity
NHTC has a Current Ratio of 3.21. This indicates that NHTC is financially healthy and has no problem in meeting its short term obligations.
NHTC has a better Current ratio (3.21) than 72.97% of its industry peers.
A Quick Ratio of 3.00 indicates that NHTC has no problem at all paying its short term obligations.
The Quick ratio of NHTC (3.00) is better than 78.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.21 | ||
| Quick Ratio | 3 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 66.67% over the past year.
The earnings per share for NHTC have been decreasing by -55.18% on average. This is quite bad
The Revenue for NHTC has decreased by -10.61% in the past year. This is quite bad
NHTC shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -25.54% yearly.
EPS 1Y (TTM)66.67%
EPS 3Y-10.86%
EPS 5Y-55.18%
EPS growth Q2Q50%
Revenue 1Y (TTM)-10.61%
Revenue growth 3Y-10.9%
Revenue growth 5Y-25.54%
Revenue growth Q2Q-12.57%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 141.00, NHTC can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of NHTC is on the same level as its industry peers.
When comparing the Price/Earnings ratio of NHTC to the average of the S&P500 Index (28.83), we can say NHTC is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 141 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NHTC has a Yearly Dividend Yield of 11.36%, which is a nice return.
NHTC's Dividend Yield is rather good when compared to the industry average which is at 5.36. NHTC pays more dividend than 97.30% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, NHTC pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.36% |
5.2 History
The dividend of NHTC decreases each year by -21.95%.
NHTC has paid a dividend for at least 10 years, which is a reliable track record.
NHTC has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-21.95%
Div Incr Years0
Div Non Decr Years4
5.3 Sustainability
NHTC pays out 1622.36% of its income as dividend. This is not a sustainable payout ratio.
NHTC's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP1622.36%
EPS Next 2YN/A
EPS Next 3YN/A
NATURAL HEALTH TRENDS CORP
NASDAQ:NHTC (5/16/2024, 7:07:05 PM)
After market: 7 -0.05 (-0.71%)7.05
+0.19 (+2.77%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap81.22M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.36% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 141 | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.82% | ||
| ROE | 1.37% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | 1.29% | ||
| GM | 74.57% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.21 | ||
| Quick Ratio | 3 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)66.67%
EPS 3Y-10.86%
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-10.61%
Revenue growth 3Y-10.9%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y